biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Outlook for in 2025: more than a transition year How Supply and Demand for

Learn about the benefits that come with our prescription drug coverage

A Renewed Look at an Old Controversy Ever since GLP-1 receptor agonists (GLP-1 RAs) entered clinical practice for diabetes and obesity, their metabolic benefits have been undeniable

GLP-1s like Ozempic, Wegovy, and Mounjaro have gained a lot of media attention for weight loss, but how do these weight-loss injections work

HIPAA, OSHA, ADA, state laws, waivers, contracts and more

Diabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.

Enroll now for expert-led certification, clinical tools, and proven strategies.